A detailed history of Raleigh Capital Management Inc. transactions in Insulet Corp stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 73 shares of PODD stock, worth $18,988. This represents 0.01% of its overall portfolio holdings.

Number of Shares
73
Previous 75 2.67%
Holding current value
$18,988
Previous $15,000 6.67%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$180.69 - $239.01 $361 - $478
-2 Reduced 2.67%
73 $16,000
Q2 2024

Jul 31, 2024

BUY
$161.02 - $206.98 $6,440 - $8,279
40 Added 114.29%
75 $15,000
Q1 2024

May 13, 2024

SELL
$163.6 - $209.11 $46,626 - $59,596
-285 Reduced 89.06%
35 $5,000
Q4 2023

Feb 21, 2024

BUY
$127.77 - $221.42 $40,886 - $70,854
320 New
320 $69,000
Q2 2023

Jul 25, 2023

BUY
$272.48 - $330.23 $14,713 - $17,832
54 New
54 $15,000
Q3 2022

Nov 09, 2022

BUY
$224.6 - $281.45 $2,919 - $3,658
13 New
13 $3,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.1B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Raleigh Capital Management Inc. Portfolio

Follow Raleigh Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raleigh Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raleigh Capital Management Inc. with notifications on news.